Teva Pharmaceutical Industries Limited (TEVJF) is expected to report earnings on Wednesday, November 11, 2026, after the close. Estimated release time 07:00 ET. Consensus EPS estimate is $0.73.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-04-29 | FY2026 Q1 | $0.45 | $0.32 | -29.5% | $3.98B |
| 2026-02-03 | FY2025 Q4 | $0.64 | $0.93 | +46.2% | $4.71B |
| 2025-11-05 | FY2025 Q3 | $0.68 | $0.77 | +12.3% | $4.48B |
| 2025-07-30 | FY2025 Q2 | $0.62 | $0.66 | +6.8% | $4.18B |
| 2025-05-07 | FY2025 Q1 | $0.46 | $0.50 | +9.9% | $3.89B |
| 2025-02-05 | FY2024 Q4 | $0.70 | $0.70 | +0.4% | $4.23B |
| 2024-11-06 | FY2024 Q3 | $0.66 | $0.69 | +4.1% | $4.33B |
| 2024-07-31 | FY2024 Q2 | $0.54 | $0.61 | +13.5% | $4.16B |
TEVJF has beaten consensus EPS in 7 of its last 8 reported quarters.
See TEVJF on the live calendar →